Skip to content
value.today

MusclePharm Corp

Total raised
$11 M
4 rounds on record
Latest round
$3 M
Aug 2013
First round on record
Jul 2012
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of MusclePharm Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2013$3 MNo. 4$2 to $10 million

MusclePharm Corp: Raise no. 4, Aug 2013

Investors in this round

6 investors had bought by the notice of Aug 14, 2013: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$25 million to $100 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Brad J. Pyatt · Executive Officer, Director · Co-Chairman of the Board, CEO and President
  • Cory J. Gregory · Executive Officer · Executive Vice-President of Brand Awareness and Social Media
  • Gary L. Davis · Executive Officer · CFO
  • John H. Bluher · Executive Officer, Director · Executive Vice President
  • Richard W. Estalella · Executive Officer, Director · Chief Operations Officer
  • Daniel W. McClory · Director
  • Donald W. Prosser · Director
  • James J. Greenwell · Director
  • Michael J. Doron · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brad Pyatt, Co-Chairman, CEO, and President. Source: SEC Form D, newest notice filed Aug 14, 2013. Read the notice at the SEC.

equitySEC
Jun 2013$2 MNo. 3Under $2 million

MusclePharm Corp: Raise no. 3, Jun 2013

Investors in this round

1 investor had bought by the notice of Jun 6, 2013: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$25 million to $100 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Brad J. Pyatt · Executive Officer, Director · Co-Chairman of the Board, Chief Executive Officer and President
  • Cory J. Gregory · Executive Officer · Executive Vice President
  • Gary L. Davis · Executive Officer · Chief Financial Officer
  • Jeremy R. DeLuca · Executive Officer · Executive Vice President - Chief Marketing Officer
  • John H. Bluher · Executive Officer, Director · Co-Chairman of the Board and Executive Vice President - Chief Operating Officer
  • Richard W. Estalella · Executive Officer · Chief Operations Officer
  • Donald W. Prosser · Director
  • James J. Greenwell · Director
  • Michael J. Doron · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brad J. Pyatt, Co-Chairman of the Board, CEO and President. Source: SEC Form D, newest notice filed Jun 6, 2013. Read the notice at the SEC.

equitySEC
Mar 2013$6 MNo. 2$2 to $10 million

MusclePharm Corp: Raise no. 2, Mar 2013

Investors in this round

3 investors had bought by the notice of Apr 9, 2013: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$25 million to $100 million
Sales commissions
$149,325
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Nevada

People named in the notice

  • Brad J. Pyatt · Executive Officer, Director · Co-Chairman, President, and CEO
  • Cory J. Gregory · Executive Officer · EVP
  • Jeremy R. DeLuca · Executive Officer · Chief Marketing Officer and EVP
  • John H. Bluher · Executive Officer, Director · Co-Chairman, COO, and EVP
  • L. Gary Davis · Executive Officer · CFO
  • Donald W. Prosser · Director
  • James J. Greenwell · Director
  • Michael J. Doron · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • StreetCapital, Inc. (CRD 104034) · Roswell, GeorgiaSold in CA
  • GVC Capital LLC (CRD 38923) · Greenwood Village, ColoradoSold in CA

Signed by Brad Pyatt, Chairman, President and CEO. Source: SEC Form D, newest notice filed Apr 9, 2013. Read the notice at the SEC.

equitySEC
Jul 2012$1 MNo. 1Under $2 million

MusclePharm Corp: Raise no. 1, Jul 2012

Investors in this round

6 investors had bought by the notice of Jul 27, 2012: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $1 M still to sell
Smallest investment taken
$10,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$25 million to $100 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$50,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Nevada

People named in the notice

  • Brad Pyatt · Executive Officer, Director
  • Cory Gregory · Executive Officer, Director
  • Jeremy H DeLuca · Executive Officer
  • John H Bluher · Executive Officer
  • Lewis Gary Davis · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Salaries to Officers”

Signed by John H. Bluher, Chief Operating Officer. Source: SEC Form D, newest notice filed Jul 27, 2012. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • MusclePharm Corp had revenue between $25 million and $100 million when it filed its newest notice of a funding round (Aug 2013).

    SEC Form D (revenue range) · Aug 2013

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Aug 2013

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of MusclePharm Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 6 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by MusclePharm Corp
NameRoleNamed in
Brad J. PyattCo-Chairman of the Board, CEO and PresidentAug 2013
Cory J. GregoryExecutive Vice-President of Brand Awareness and Social MediaAug 2013
Gary L. DavisCFOAug 2013
John H. BluherExecutive Vice PresidentAug 2013
Richard W. EstalellaChief Operations OfficerAug 2013
Jeremy R. DeLucaExecutive Vice President - Chief Marketing OfficerJun 2013
L. Gary DavisCFOApr 2013
Brad PyattExecutive officerJul 2012
Cory GregoryExecutive officerJul 2012
Jeremy H DeLucaExecutive officerJul 2012
John H BluherExecutive officerJul 2012
Lewis Gary DavisExecutive officerJul 2012
Brad J. PyattCo-Chairman of the Board, CEO and PresidentAug 2013
Daniel W. McCloryDirectorAug 2013
Donald W. ProsserDirectorAug 2013
James J. GreenwellDirectorAug 2013
John H. BluherExecutive Vice PresidentAug 2013
Michael J. DoronDirectorAug 2013
Richard W. EstalellaChief Operations OfficerAug 2013
Brad PyattDirectorJul 2012
Cory GregoryDirectorJul 2012